Pentobarbital Sodium

戊巴比妥钠

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NamePentobarbital Sodium
Drug Alias NamePentobarbitone Sodium巴比妥钠盐戊巴比妥纳戊巴比妥钠盐Nembutal
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSedationSleep Initiation and Maintenance Disorders
Global Approved IndicationsSedationSleep Initiation and Maintenance Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSedationSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN05CA01